Close

Welcome back to Stockhouse
Member Sign In

Email or Username:
Password:
Close

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Enter your email address:
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Quote  |  Bullboard  |  News  |  Opinion  |  Level II  |  Charts  |  Profile  |  Financials  |  Options  |  Price History  |  Analysts  |  Earnings  |  Insiders

BiOasis Technologies Inc V.BTI

Sector: Healthcare | Sub-Sector: Biotechnology
Alternate Symbol(s):  BIOAF

biOasis Technologies Inc is a biopharmaceutical company focused on the delivery of therapeutics across the blood-brain barrier and into the brain tissue. Its focus is to address unmet medical needs with its proprietary Transcend Platform.
Price: $1.26 | Change: $-0.04 | %Change: -3.08%
Volume: 900 | Day High/Low: 1.26/1.26 | 52 Week High/Low: 1.50/0.75
View modes: 
0 stars

RE:RE:RE:RE:RE:RE:RE:RE:Transcendpep vs. Angiopep

KBC, JD, Sir Holler, thanks for all the info. Very educational and helps a lot. Have a good weekend.  rate and reply
0 stars

RE:RE:RE:RE:RE:RE:RE:Transcendpep vs. Angiopep

....Altogether it looks like somewhere between 10 to 20 studies have been done or are in progress with fusion proteins based on MTfp.... JD, I'm not sure I realized there were that many MTfp studies....read more
5 stars

RE:RE:RE:RE:RE:RE:Transcendpep vs. Angiopep

Everything that biOasis has done over the last couple of years has been done with fusion proteins, including all of MedImmune's work with several of their therapeutics, which were described by biOasis...read more
0 stars

RE:RE:RE:RE:RE:Transcendpep vs. Angiopep

What specifically has Bioasis used fusion proteins for with Transendpep?  rate and reply
0 stars

RE:RE:RE:RE:Transcendpep vs. Angiopep

To be fair to Ralph Weissleder et al, I messed up the title to their book... Molecular Imaging: Principles and Practice By Ralph Weissleder et al, 2010 Fusion Protein versus Conjugation An...read more
5 stars

RE:RE:RE:Transcendpep vs. Angiopep

A bit more on fusion proteins vs conjugates (with link fixed).... Fusion Protein versus Conjugation By Ralph Weissleder et al, 2010 Fusion Protein versus Conjugation An overarching question is why...read more
0 stars

RE:RE:Transcendpep vs. Angiopep

A bit more on fusion proteins vs conjugates.... [url= http://bit.ly/1JDbApH]Fusion Protein versus Conjugation[/url] By Ralph Weissleder et al, 2010 Fusion Protein versus Conjugation An overarching...read more
5 stars

RE:Transcendpep vs. Angiopep

BearDownAZ, I'm not going to throw Angiochem under the bus but the fact is, it appears that they cannot do the things that biOasis can do. They have not shown that they're a serious competitor to...read more
0 stars

RE:RE:RE:Transcendpep vs. Angiopep

900 shares traded so far?...I think this needs more pumping......kayacker and the likes....your weekend shift should be starting soon here.....don't be late  rate and reply
0 stars

RE:RE:RE:Transcendpep vs. Angiopep

"The half-life of what?  Described on what page of the presentation?" Getting a drug over the blood-brain barrier efficiently is one objective of drug development. Keeping therapeutic levels of the...read more
0 stars

RE:RE:Transcendpep vs. Angiopep

"In the Bioasis presentation available on the Bioasis website..." Transport rate is nice but look at how rapid the half-life is. The half-life of what?  Described on what page of the presentation?  rate and reply
0 stars

RE:Transcendpep vs. Angiopep

"In the Bioasis presentation available on the Bioasis website..." Transport rate is nice but look at how rapid the half-life is.  rate and reply
0 stars

RE:RE:RE:RE:Transcendpep vs. Angiopep

Thanks KBC. I should have linked to that 2013 discussion, since I started that one too! Angiochem recently presented at the 2015 AACR meeting on their Angiopep-2/anti HER2 mAB conjugate. Abstract...read more
0 stars

RE:RE:RE:Transcendpep vs. Angiopep

FWIW, a prior discussion of AngioChem started here in 2013. Scroll forward for a few responses.  Wouldn't hurt to understand where they are now in 2015.  rate and reply
0 stars

RE:RE:Transcendpep vs. Angiopep

BTW, ANG1005/GER1005 is a combination of Angiopep-2 fused to the anti-cancer drug Paclitaxel. Angiopep-2 seems to be Angiochems peptide of choice.  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2538693...read more
0 stars

RE:Transcendpep vs. Angiopep

Despite Geron terminating their license agreement with Angiopep for GER1005 (now ANG1005) due to what seemed to be ineffectiveness, Angiochem still soldiered on with this and just recently received...read more
0 stars

Transcendpep vs. Angiopep

Both Bioasis and Angiochem (http://angiochem.com/) have technologies that allow for a Transcendpep (MTfp) or Angiopep peptide to be added to drugs, antibodies, shRNAs, etc to elicit receptor mediated...read more
3.5 stars

Still buying FWIW

The last NR presages some licensing deals at some point. The volume and price action don't lead me to believe this news is short term but I a hope I am wrong. The technology still is disruptive and...read more
2 stars

The puzzle.

The outside of the puzzle is finished, all of the other pieces are starting to fall into place, from what I can tell the Bioasis team are top notch puzzle builders...........In short that beautiful...read more
2.5 stars

RE:change of ways

to answer a question from 1 of the 5 i'm off this forum for good Not again! LOL.  Off this forum for good?  No you're not.  You'll be back soon.  Guaranteed.  It's really a bad idea to post that...read more